Fracticide among CD8+ T lymphocytes naturally infected with human T cell lymphotropic virus type I

Immunity

Volumn 13, Issue 5, 2000, Pages 657-664

  Hanon, Emmanuel ^a   Stinchcombe, Jane C ^b   Saito, Mineki ^a   Asquith, Becca E ^a   Taylor, Graham P ^a   Tanaka, Yuetsu ^c   Weber, Jonathan N ^a   Griffiths, Gillian M ^b   Bangham, Charles R M ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CD8 ANTIGEN; TAX PROTEIN;

ARTICLE; CELL MEDIATED CYTOTOXICITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE RESPONSE; INFECTION RISK; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; VIRUS INFECTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOTOXICITY; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOLOGY; VIROLOGY;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS;

EID: 0033622479     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)00065-0     Document Type: Article

References (38)

1. Phenotypic analysis of antigen-specific T lymphocytes
2. Direct quantitation of rapid elimination of viral antigen-positive lymphocytes by antiviral CD8(+) T cells in vivo
3. The binding and lysis of target cells by cytotoxic lymphocytes: Molecular and cellular aspects
4. Regulation of gene expression by HTLV-I Tax protein
5. Direct analysis of viral-specific CD8+ T cells with soluble HLA- A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy
6. In vivo proviral burden and viral RNA expression in T cell subsets of patients with human T lymphotropic virus type-1-associated myelopathy/tropical spastic paraparesis
7. Decline of natural cytotoxicity of human lymphocytes following infection with human T-cell leukemia/lymphoma virus (HTLV)
8. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
9. Cell surface phenotype and human T lymphotropic virus type 1 antigen expression in 12 T cell lines derived from peripheral blood and cerebrospinal fluid of West Indian, Guyanese and African patients with tropical spastic paraparesis
10. Abundant Tax protein expression in CD4+ T cells infected with human T-cell leukaemia virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes
11. TCR-mediated internalization of peptide-MHC complexes acquired by T cells
12. The effect of human T cell leukaemia virus type I infection on a herpes simplex virus-specific CD8+ cytotoxic T cell clone
13. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease
14. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy
15. Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells
16. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin and Fas-based lytic pathways in cell-mediated cytotoxicity
17. In vivo infection of human T-cell leukemia virus type I in non-T cells
18. Specific adsorption of HTLV-I to various target human and animal cells
19. Monoclonal antibody defining tax protein of human T-cell leukemia virus type-I
20. Dendritic cells from patients with tropical spastic paraparesis are infected with HTLV-1 and stimulate autologous lymphocyte proliferation
21. The role of human T-lymphotropic virus type 1 (HTLV-1)-infected dendritic cells in the development of HTLV-1-associated myelopathy/tropical spastic paraparesis
22. Analyzing cytotoxic T lymphocyte activity: A simple and reliable flow cytometry-based assay
23. Efficient transformation of previously activated and dividing T lymphocytes by human T cell leukemia-lymphoma virus
24. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells
25. The transactivator gene of human T-cell leukemia virus type I is more variable within and between healthy carriers than patients with tropical spastic paraparesis
26. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis
27. Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously
28. Isolation and transmission of human retrovirus (human t-cell leukemia virus)
29. Alteration of T-cell functions by infection with HTLV-I or HTLV-II
30. A simple and sensitive flow cytometric assay for the determination of the cytotoxic activity of human natural killer cells
31. Herpes simplex virus type 1 infection of activated cytotoxic T cells: Induction of fratricide as a mechanism of viral immune evasion
32. In vivo cellular tropism of human T-cell leukemia virus type 1
33. Human T cell leukemia viruses use a receptor determined by human chromosome 17
34. Cognate peptide-induced destruction of CD8+ cytotoxic T lymphocytes is due to fratricide
35. Human T cell leukemia virus type I (HTLV-I) and human diseases
36. Cognate peptides induce self-destruction of CD8+ cytolytic T lymphocytes
37. Alterations in cytotoxic and helper T cell function after infection of T cell clones with human T cell leukemia virus, type I
38. General and specific immunosuppression caused by antiviral T-cell responses